Does OMALIZUMAB Cause Injection site swelling? 387 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 387 reports of Injection site swelling have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.6% of all adverse event reports for OMALIZUMAB.
387
Reports of Injection site swelling with OMALIZUMAB
0.6%
of all OMALIZUMAB reports
4
Deaths
122
Hospitalizations
How Dangerous Is Injection site swelling From OMALIZUMAB?
Of the 387 reports, 4 (1.0%) resulted in death, 122 (31.5%) required hospitalization, and 13 (3.4%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 387 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which OMALIZUMAB Alternatives Have Lower Injection site swelling Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS